Alzheimer’s risk gene APOE4 may have a reversible weakness
The Genetic Culprit: APOE4 and Brain Health Alzheimer’s disease, a progressive neurodegenerative disorder, currently affects more than 7 million Americans. The APOE4 variant of the apolipoprotein E gene has long…
Alzheimer’s risk gene APOE4 may have a reversible weakness
For decades, the medical community has viewed the deterioration of brain blood vessels as a secondary symptom of Alzheimer’s disease—a passive consequence of the inevitable decline in cognitive function. However,…
The APOE2 Gene Variant Offers Enhanced Neuronal Protection Against DNA Damage and Cellular Senescence, Unlocking New Avenues for Alzheimer’s Research
For years, the scientific community has recognized a significant advantage conferred by the APOE2 variant of the apolipoprotein E gene: individuals carrying it tend to enjoy longer lifespans and exhibit…
The APOE Gene and Meat Consumption: A New Frontier in Alzheimer’s Risk Mitigation
A groundbreaking study emerging from the Karolinska Institutet in Sweden is challenging long-held assumptions about diet and Alzheimer’s disease risk, particularly for individuals carrying specific genetic predispositions. Researchers have uncovered…










